Anti-IL-10 mAb protection against experimental Visceral leishmaniasis via induction of Th1 cytokines and nitric oxide

Indian Journal of Experimental Biology

Volumn 47, Issue 6 SPEC. ISS., 2009, Pages 489-497

  Bhattacharjee, Surajit ^a   Gupta, Gaurav ^a   Bhattacharya, Parna ^a   Adhikari, Anupam ^a   Majumdar, Suchandra Bhattacharya ^a   Majumdar, Subrata ^a  

^a BOSE INSTITUTE   (India)

Author keywords

Anti IL 10 monoclonal antibody; Leishmaniasis; Nitric oxide; Th1 th2 cells

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN G; INTERLEUKIN 10; MONOCLONAL ANTIBODY; NITRIC OXIDE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; IMMUNOLOGY; LEISHMANIA DONOVANI; MOUSE; TH1 CELL; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIBODIES, MONOCLONAL; CYTOKINES; IMMUNOGLOBULIN G; INTERLEUKIN-10; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MICE; MICE, INBRED BALB C; NITRIC OXIDE; TH1 CELLS;

EID: 68249149641     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bates P A, The developmental biology of Leishmania promastigotes, Exp Parasitol, 79 (1994) 215.
2. Banerjee A, De M & Ali N, Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylaminebearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses, J Immunol, 181 (2008) 1386.
3. Chang K P & Choudhuri G, Molecular determinates of Leishmania virulence, Annu Rev Microbiol, 44 (1990) 499.
4. (Pubitemid 350132638) Dey R, Majumder N, Bhattacharyya Majumdar S, Bhattacharjee S, Banerjee S, Roy S & Majumdar S, Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice, Scand J Immunol, 66 (2007) 671.
5. (Pubitemid 26087453) Wilson M E, Sandor M, Blum A M, Young B M, Metwali A, Elliot D, Lynch R G & Weinstock J V, Local suppression of IFN-gamma in hepatic granulomas correlates with tissue specific replication of Leishmania chagasi, J Immunol, 156 (1996) 2231.
6. (Pubitemid 28018796) Melby P C, Yang Y Z, Cheng J & Zhao W, Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani, Infect Immun, 66 (1998) 18.
7. Fiorentino D F, Bond M W & Mosmann T R, Two types of mouse T helper cell. IV. Th 2 clones secrete a factor that inhibits cytokine production by Th 1 clones, J Exp Med, 170 (1996) 1989.
8. (Pubitemid 18217889) Fernandez-Botran, Sanders V M, Mosmann T R, Vitetta E, Lymphokine mediate regulation of the proliferative of clones of T helper 1 and T helper 2 cells, J Exp Med, 168 (1988) 543.
9. De Wall Malefyt R, Abrams J, Bennet B, Figdor C & de Vries J, IL-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes, J Exp Med, 174 (1991) 1209.
10. Go N F, Castle B E, Barrett R, Kastelein R, Dang W, Mosmann T R, Moore K W & Howard M, Interleukin 10, a novel B cell stimulatory factor :unresponsiveness of X chomosome linked immunodeficiency B cells, J Exp Med, 172 (1990) 1625.
11. Thompson-Snipes L, Dhar LV, Bond M W, Mosmann T R, Moore K W & Rennieck D M, Interleukin-10: a novel stimulatory factor for mast cells and their progenitors, J Exp Med, 173 (1991) 507.
12. Mizuno T, Sawada M, Marunoouchi T & Suzumura A, Production of Interleukin-10 by mouse glial cells in culture, Biochem Biophys Res Commun, 205 (1994) 1007.
13. Mosmann T R & Moore K W, The role of IL-10 in cross regulation of TH1 and TH2 responses, Immunol Today, 1991 (1991) 49.
14. Fiorentino D F, Zlotnik A, Vieire P, Mosmann T R, Howard M, Moore K W, O'Garra A, IL-10 acts on the antigen presenting cells to inhibit cytokine production by TH1 cells, J Immunol, 164 (1991) 3444.
15. Bogdan C, Vodovotz Y & Nathan C, Macrophage deactivation by Interleukin-10, J Exp Med, 174 (1991) 1549.
16. Brandtzaeg P, Osnes L, Ovstebo R, Joo G B, Westvik A B & Kierulz P, Net inflammatory capacity of human septic shock plasma evaluated by a monocyte based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes, J Exp Med, 184 (1996) 51.
17. (Pubitemid 23344879) Cassatella M A, Meda L, Bonora A, Ceska M & Constantin G, Interleukin-10 (IL-10) inhibit release of proinflammatory cytokines from human polymorphonuclear leukocytes: evidence for an autocrine role tumour necrosis factor and IL-1 in mediating the production of IL-8 triggered by lypopolysaccharide, J Exp Med, 178 (1993) 2207.
18. (Pubitemid 26324128) Koch F, Stanzl U, Jennewein P, Janke K, Heufter C, Kampgen E, Romani N & Schuler G, High levels IL-12 production by murine dendritic cells: upregulation via MHC class II and CD 40 molecules and down regulation by IL-14 and IL-10, J Exp Med, 184 (1996) 741.
19. (Pubitemid 24098053) Kasama T, Strieter R M, Lukacs N W, Burdick M D & Kunkel S L, Regulation of neutrophil derived chemokine expression by IL-10, J Immunol, 152 (1994) 3559.
20. Gazzinelli R T, Oswald I P, James S L & Sher A, IL-10 inhibits parasite killing and nitric oxide production by IFN-γ activated macrophages, J Immunol, 148 (1992) 1792.
21. (Pubitemid 24311260) Vieth M, Will A, Schoppel K, Rollinghoff M & Gessner A, Interleukin-10 inhibits antimicrobial activity against Leishmanial major in murine macrophages, Scand J Immunol, 40 (1994) 403.
22. (Pubitemid 32187601) Bhattacharyya S, Ghosh S, Jhonson P L, Bhattacharya S K & Majumdar S, Immunomodulatory role of interleukin-10 in visceral leishmaniasis: Defective activation of Protein kinase C mediated signal transduction events, Infect Immun, 69 (2001) 1499.
23. (Pubitemid 23182316) Bermudez L F & Champsi J, Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti IL-10 antibody is associated with enhance resistence to infection in mice. Infect Immun, 61 (1993) 3093.
24. Greenberger M J, Strieter R M, Kunkel S L, Danforth J M, Goodman R E & Standiford T J. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia, J Immunol, 155 (1995) 722.
25. (Pubitemid 11084017) Hart T D, Vickerman K, Coombs G H et al., Simple method for purifying L. mexicana amastigotes in large numbers. Parasitology, 82 (1981) 345.
26. Stauber L A, Host resistance to the Khartoum strain of Leishmania donovani, Rice Institute Pamphlet, 45 (1958) 80.
27. (Pubitemid 350132638) Dey R, Majumder N, Majumdar-Bhattacharyya S, Bhattacharjee S, Roychoudhury K, Banerjee S, Roy S & Majumdar S, Induction of host protective Th1 immune response by chemokines in leishmania donovani infected BALB/c mice, Scan J Immunol, 66 (2007) 671.
28. Saha B, Roy H N, Pakrashi A, Chkrabarti R N & Roy S, Immunobiological studies on experimental visceral leishmaniasis. I. Changes in lymphoid organs and thenpossible role in pathogenesis, Eur J Immunol, 21 (1991) 577.
29. Chomezynasky P & Sacchi N, A single step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction, Anal Biochem, 162 (1987) 156.
30. Sambrook J, Fritsch E F & Maniatis T, Molecular cloning: A laboratory manual (Cold Spring Harbor Laboratory Press, NY, USA) 1989.
31. (Pubitemid 13203451) Green L C, Wagner D A, Glogowski J, Skipper P L, Wishnok J S, Tannenbaum S R, Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids, Anal Biochem, 126 (1982) 131.
32. (Pubitemid 17009584) Hibbs J B Jr, Taintor R R, Vavrin Z, Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite, Science, 235 (1987) 473.
33. (Pubitemid 14230268) Haldar J P, Ghose S, Saha K C & Ghose A C, Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis, Infect Immun, 42 (1983) 702.
34. Gifawesen C & Farrell J P, Comparison of T-cell responses in selflimiting versus progressive visceral Leishmania donovani infections in golden hamsters, Infect Immun, 57 (1989) 3091.
35. Miralles G D, Stoeckle M Y, McDermott D F, Finkelman F D & Murray H W, Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis, Infect Immun, 62 (1994) 1058.
36. Murray H W, Stern J J, Welte K, Rubin B Y, Carriero S M & Nathan C F, Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma, J Immunol, 138 (1987) 2290.
37. (Pubitemid 36245653) Gantt K R, Schultz-Cherry S, Rodriguez N, Jeronimo S M, Nascimento E T, Goldman T L, Recker T J, Miller M A & Wilson M E Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages, J Immunol, 1702 (2003) 613.
38. (Pubitemid 26028923) Krishnan L, Guilbert L J, Russell A S, Wegmann T G, Mosmann T R & M Belosevic, Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines, J Immunol, 156 (1996) 644.
39. Murray H W & Nathan C F, Macrophage microbicidal mechanisms in vivo: Reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani, J Exp Med, 189 (1999) 741.
40. Wagner R D, Maroushek N M, Brown J F & Czuprynski C J, Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice, Infect Immun 62 (1994) 2345.
41. (Pubitemid 27153653) Vouldoukis I, Bécherel PA, Riveros-Moreno V, Arock M, da Silva O, Debré P, Mazier D & Mossalayi MD, Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation, Eur J Immunol, 27 (1997) 860.
42. (Pubitemid 35192720) Murray H W, Lu C M, Mauze S, Freeman S, Moreira A L, Kaplan G & Coffman R L, Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy, Infect Immun, 70 (2002) 6284.